ArticleJournal of neuro-oncology2025
The communication of a high-grade glioma diagnosis- patients' reflections and perspectives based on a study-specific questionnaire.
Article in Journal of neuro-oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo analyze the communication setting of a high-grade glioma (HGG) diagnosis, patients' emotional responses and their needs of further support and information as well as education about the disease to optimize neuro-oncological treatment.
methodsIn a single-center survey, a 10-item questionnaire was developed to analyse the setting of communication, emotional aspects, needs and impression of education or information in patients with HGG between March and May of 2024. Three questions focused on the conversation setting, two on education, one on emotional aspects, and four on patients' support. Descriptive statistics and Chi Square tests were used to analyze these multidimensional items.
resultsPatients' age ranged from 27 to 77 years (median 55), 14 patients (28%) were female, and 36 (72%) were male. Most patients (62%, 31/50) received support when informed of their diagnosis, primarily from relatives (42%, 21/50), especially life partners (22%, 11/50). A majority (64%, 32/50) were satisfied with the initial information received, while 32% (16/50) preferred additional details. Less than half of the patients (21/50, 42%) used further possibilities for support. Patients indicated their need of further information in 14% (7/50), additional support in 12% (6/50, 12%) and extended conversation time in 10%.
conclusionEach patient should receive individualized medical consultations to adequately communicate the HGG diagnosis and treatment requirements. Discussions about treatment options and recommendations should involve patients' support systems, including family members or close friends. Despite the availability of psycho-oncological support during hospitalization, ongoing community support for patients and caregivers is essential and should be promoted early. Continuous improvements in patient education, accessibility, and caregiver support will enhance coping, resilience and caregivers' mastery in neuro-oncology.
Indexed as
Identifiers
40526337What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.